GENNIEFY
Market News
Latest financial news and analysis from global markets
INTC
Why Tower Semiconductor Rallied in April
Tower Semiconductor continued its torrid run with new customer wins and continued enthusiasm for AI-related chip stocks.
LULU
Chip Wilson’s Activist Push Puts Lululemon’s Future Direction Under Scrutiny
Founder Chip Wilson has escalated his activist campaign against lululemon athletica (NasdaqGS:LULU), challenging the board over its direction and leadership choices. He is publicly opposing the incoming CEO appointment, promoting his own board nominees, and pressing for a renewed focus on lululemon's creative roots and brand identity. The campaign includes proxy efforts, shareholder letters, and criticism of recent board and executive moves, raising questions about future governance and...
NVDA
Micron Stock Is Up 700% Over the Past Year. Its Shares Still Look Relatively Cheap.
The memory company believes it's on the cusp of a multidecade growth cycle for artificial intelligence (AI) and robotics.
GOOGL
Micron Stock Is Up 700% Over the Past Year. Its Shares Still Look Relatively Cheap.
The memory company believes it's on the cusp of a multidecade growth cycle for artificial intelligence (AI) and robotics.
INTC
Micron Stock Is Up 700% Over the Past Year. Its Shares Still Look Relatively Cheap.
The memory company believes it's on the cusp of a multidecade growth cycle for artificial intelligence (AI) and robotics.
MSFT
Micron Stock Is Up 700% Over the Past Year. Its Shares Still Look Relatively Cheap.
The memory company believes it's on the cusp of a multidecade growth cycle for artificial intelligence (AI) and robotics.
AMZN
Micron Stock Is Up 700% Over the Past Year. Its Shares Still Look Relatively Cheap.
The memory company believes it's on the cusp of a multidecade growth cycle for artificial intelligence (AI) and robotics.
GILD
Stronger HIV Pipeline And Acquisition Charges Might Change The Case For Investing In Gilead Sciences (GILD)
In early May 2026, Gilead Sciences reported first-quarter 2026 results showing revenue of US$6.96 billion and net income of US$2.02 billion, alongside updated guidance that pairs higher expected product sales with an adjusted full-year earnings loss driven by very large acquisition-related charges. At the same time, Gilead advanced its HIV portfolio with FDA priority review for the once-daily bictegravir/lenacapavir combination and continued returning capital through share repurchases, even...
ABBV
AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting
AbbVie (NYSE:ABBV) told shareholders at its annual meeting that 2025 was “another excellent year” for the company, citing record sales, stronger-than-expected revenue and continued investment in its drug pipeline and business development. Rob Michael, AbbVie’s chairman and chief executive officer,
AAPL
Warren Buffett's McLane makes major bet on driverless big rigs
Warren Buffett built his fortune on a simple idea. Find sturdy businesses that print cash, leave them alone for decades, and let compound interest do the heavy lifting. That patience is why Berkshire Hathaway (BRK.A) became the kind of holding company that owns a railroad, an insurer, a battery ...
AMZN
Warren Buffett's McLane makes major bet on driverless big rigs
Warren Buffett built his fortune on a simple idea. Find sturdy businesses that print cash, leave them alone for decades, and let compound interest do the heavy lifting. That patience is why Berkshire Hathaway (BRK.A) became the kind of holding company that owns a railroad, an insurer, a battery ...
NVDA
If You'd Invested $10,000 in Oklo 1 Year Ago, Here's How Much You'd Have Today.
The stock is up right now, but that may not last.